Investment approach

healthcare expertise

Hands-on value

Investment in
disruptive research


Friedrich Ackermann

Co-Founder & President

Friedrich previously worked as a management consultant (McKinsey & Company), investment banker (Morgan Stanley), private equity analyst (Partners Group) and entrepreneur in the health care industry. He holds an MPH in Epidemiology from Yale University and an MSc in Management from the London School of Economics.

von Janowski


Daniel previously worked as M&A investment banker (Evercore), management consultant (Roland Berger) and CEO in the diagnostics industry. Daniel holds an MSc in Management from the London School of Economics and a BSc in Engineering from TU Darmstadt.

Emmanuella Asabor

Vice President- Research

Emmanuella holds a BA from Harvard University, a MA from Cambridge University and a MD-PhD from Yale University. Her research focusses on the impact of structural racism on health. At A18i, Emmanuella heads the research department. In 2022, she was included into the Forbes 30 under 30 Healthcare List.

Jeff Carlson

Vice President - Translational Science

Jeff holds a PhD in Biomedical Sciences from Baylor College of Medicine and BSc in Biochemistry and Molecular Biology from Illinois State University. He previously worked as Discovery Scientist at LakePharma and co-founded RioRaiz, a nonprofit therapy discovery organisation.

Case Studies / Subsidiaries

The A18i team founded NeraCare GmbH in 2017 and have been leading the company’s strategy and operations since. Under A18i's leadership, NeraCare raised more than $20 million in venture capital funding led by MIG Capital AG, also a founding investor of German biotech giant BioNTech. The company also set up the NivoMela trial, the first clinical trial in oncology to select patients for adjuvant treatment based on individualized risk for relapse.

A18i Capital Ltd,

17/F Glenealy Tower, No 1 Glenealy,

Central Hong Kong

A18i Consulting LLC

101 Avenue of the Americas, Fl 8/9,

New York, NY 10013, United States